A high plasma concentration of tnf-α is associated with dementia in centenarians

Journals of Gerontology - Series A Biological Sciences and Medical Sciences

Volumn 54, Issue 7, 1999, Pages

  Bruunsgaard, Helle ^a  

^a University of Copenhagen   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; INTERLEUKIN 6; LEUKOCYTE ANTIGEN; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR; TUMOR NECROSIS FACTOR RECEPTOR 2;

ADOLESCENT; ADULT; AGED; ALZHEIMER DISEASE; ARTERIOSCLEROSIS; ARTICLE; BLOOD; BODY MASS; COGNITION; FEMALE; HUMAN; LEUKOCYTE COUNT; MALE; MIDDLE AGED;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; ANTIGENS, CD; ARTERIOSCLEROSIS; BODY MASS INDEX; C-REACTIVE PROTEIN; COGNITION; FEMALE; HUMANS; INTERLEUKIN-6; LEUKOCYTE COUNT; MALE; MIDDLE AGED; RECEPTORS, TUMOR NECROSIS FACTOR; RECEPTORS, TUMOR NECROSIS FACTOR, TYPE II; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0033163270     PISSN: 10795006     EISSN: None     Source Type: Journal    
DOI: 10.1093/gerona/54.7.M357     Document Type: Article

References (66)

1. Miller RA. The aging immune system: primer and prospectus. Science. 1996;273:70-74.
2. Fagiolo U, Cossarizza A, Santacaterina S, et al. Increased cytokine production by peripheral blood mononuclear cells from healthy elderly people. Ann NYAcad Sci. 1992;663:490-493.
3. Hobbs MV, Weigle WO, Noonan DJ, et al. Patterns of cytokine gene expression by CD4+ T cells from young and old mice. J Immunol. 1993; 150:3602-3614.
4. Cohen HJ, Pieper CF, Harris T, Rao KK, Currie MS. The association of plasma IL-6 levels with functional disability in community dwelling elderly. 3 Gerontol Med Sci. 1997;52A:M201-M208.
5. Wei J, Xu H, Davies JL, Hemmings GP. Increase of plasma IL-6 concentration with age in healthy subjects. Life Sci. 1992;51:1953-1956.
6. James K, Premchand N, Skibinska A, Skibinski G, Nicol M, Mason JI. IL-6, DHEA and the ageing process. Mech Ageing Dev. 1997;93:15-24.
7. Hager K, Machein U, Krieger S, Platt D, Seefried G, Bauer J. Interleukin6 and selected plasma proteins in healthy persons of different ages. Neurobiol Aging. 1994;15:771-772.
8. Kania DM, Binkley N, Checovich M, Havighurst T, Schilling M, Ershler WB. Elevated plasma levels of interleukin-6 in postmenopausal women do not correlate with bone density. J Am Geriatr Soc. 1995;43:236-239.
9. Ershler WB, Sun WH, Binkley N, et al. Interleukin-6 and aging: blood levels and mononuclear cell production increase with advancing age and in vitro production is modifiable by dietary restriction. Lympnokine Cytokine Res. 1993;12:225-230.
10. Catania A, Airaghi L, Motta P, et al. Cytokine antagonists in aged subjects and their relation with cellular immunity. J Gemntol Biol Sci. 1997;52A:B93-B97.
11. Peterson PK, Chao CC, Carson P, Hu S, Nichol K, Janoff EN. Levels of tumor necrosis factor alpha, interleukin 6, interleukin 10, and transforming growth factor beta are normal in the serum of the healthy elderly. Clin Infect Dis. 1994;19:1158-1159.
12. Mooradian AD, Reed RL, Osterweil D, Clements N, Scuderi P. Lack of an association between the presence of tumor necrosis factor or interleukin-1 alpha in the blood and weight loss among elderly patients. J Am Geriatr Soc. 1990;38:397-401.
13. Huberman M, Sredni B, Stern L, Kott E, Shalit F. IL-2 and IL-6 secretion in dementia: correlation with type and severity of disease. J Neural Sci. 1995;130:161-164.
14. Hull M, Strauss S, Berger M, Volk B, Bauer J. Inflammatory mechanisms in Alzheimer's disease. EurArch Psychiatry Clin Neumsci. 1996;246:124-128.
15. Ross R. The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature. 1993;362:801-809.
16. Haverkate F, Thompson SG, Pyke SD, Gallimore JR, Pepys MB. Production of C-reactive protein and risk of coronary events in stable and unstable angina. European Concerted Action on Thrombosis and Disabilities Angina Pectoris Study Group. Lancet. 1997;349:462-466.
17. Kaiman J, Juhasz A, Laird G, et al. Serum interleukin 6 levels correlate with the severity of dementia in Down syndrome and in Alzheimers disease. Acta Neurolog Scand. 1997;96:236-240.
18. Ershler WB. Interleukin-6: a cytokine for gerontologists. J Am Geriatr Soc. 1993:41:176-181.
19. Ridker PM, Cushman M, Stampfer MJ, Tracy RP, Hennekens CH. Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men. NEnglJMed. 1997;336:973-979.
20. Mooradian AD, Reed RL, Osterweil D, Scuderi P. Detectable serum levels of tumor necrosis factor alpha may predict early mortality in elderly institutionalized patients. J Am Geriatr Soc. 1991:39:891-894.
21. Meda L, Cassatella MA, Szendrei GI, et al. Activation of microglial cells by beta-amyloid protein and interferon-gamma. Nature. 1995:374:647-650.
22. Bongioanni P, Romano MR, Sposito R, Castagna M, Boccardi B, Borgna M. T-cell tumour necrosis factor-alpha receptor binding in demented patients. J Neural. 1997;244:418-425.
23. Cacabelos R, Femandez NL, Perez TJ, Franco MA, Alvarez XA. Serum histamine in Alzheimer's disease and multi-infarct dementia. Meth Find Exp Clin Pharmacol. 1992;14:711-715.
24. Franceschi C, Monti D, Sansoni P, Cossarizza A. The immunology of exceptional individuals: the lesson of centenarians. Immunol Today. 1995:16:12-16.
25. Olsen H, Jeune B, Andersen RK. Centenarians in the county of Funen. Morbidity and functional capacity [in Danish]. Ugeskr Laeger. 19%;158: 7397-7401.
26. Jensen GD, Polloi AH. The very old of Palau: health and mental state. Age Ageing. 1988:17:220-226.
27. Powell AL. Senile dementia of extreme aging: a common disorder of centenarians. Dementia. 1994:5:106-109.
28. Sobel E, Louhija J, Sulkava R, et al. Lack of association of apolipoprotein E allele epsilon 4 with late-onset Alzheimer's disease among Finnish centenarians. Neurology. 1995;45:903-907.
29. Asada T, Yamagata Z, Kinoshita T, et al. Prevalence of dementia and distribution of ApoE alleles in Japanese centenarians: an almost-complete survey inYamanashi Prefecture, Japan. J Am Geriatr Soc. 1996:44:151-155.
30. Richards C, Gauldie J. Role of cytokines in the acute-phase response. In: Aggarwal BB, Puri RK, eds. Human Cytokines: Their Roles in Disease and Therapy. Cambridge, MA: Blackwell Science; 1995:253-269.
31. Zheng ZJ, Sharrett AR, Chambless LE, et al. Associations of anklebrachial index with clinical coronary heart disease, stroke and preclinical carotid and popliteal atherosclerosis: the Atherosclerosis Risk in Communities (ARIC) Study. Atherosclerosis. 1997;131:115-125.
32. Newman AB, Siscovick DS, Manolio TA, et al. Ankle-arm index as a marker of atherosclerosis in the Cardiovascular Health Study. Cardiovascular Heart Study (CHS) Collaborative Research Group. Circulation. 1993;88:837-845.
33. McDermott MM, Feinglass J, Slavensky R, Pearce WH. The anklebrachial index as a predictor of survival in patients with peripheral vascular disease. J Gen Intern Med. 1994;9:445-449.
34. Cederholm T, Hellstrom K. Nutritional status in recently hospitalized and free-living elderly subjects. Gerontology. 1992;38:105-110.
35. Schroll M, Avlund K, Davidsen M. Predictors of five-year functional ability in a longitudinal survey of men and women aged 75 to 80. The 1914population in Glostrup, Denmark. Aging Milano. 1997;9:143-152.
36. World Health Organization (WHO). The ICD-10 Classification of Mental and Behavioural Disorders. Clinical Descriptions and Diagnostic Guidelines. Geneva: WHO; 1992.
37. Folstein MF, Folstein SE, McHugh PR. Mini-Mental State. A practical method for grading the cognitive state of patients for the clinician. J PsychiatrRes. 1975;12:189-198.
38. Lawton MP, Brody EM. Assessment of older people: self-maintaining and instrumental activities of daily living. Gemntologist. 1969;9:179-186.
39. Hughes CP, Berg L, Martin RL. A new clinical stage for the staging of dementia. Br JPsychiatry. 1982; 140:566-572.
40. Haboubi NY, Hudson PR, Pathy MS. Measurement of height in the elderly. JAm GeriatrSoc. 1990;38:1008-1010.
41. Moldawer LL, Marano MA, Wei H, et al. Cachectin/tumor necrosis factor-alpha alters red blood cell kinetics and induces anemia in vivo. FASEB J. 1989;3:1637-1643.
42. Ligthart GJ, Corberand JX, Founder C, et al. Admission criteria for immunogerontological studies in man: the SENTEUR protocol. Mech Ageing Dev. 1984;28:47-55.
43. Gutierrez-Ramos JC, Bluethmann H. Molecules and mechanisms operating in septic shock: lessons from knockout mice. Immunol Today. 1998; 18:329-334.
44. De GD, Zangerle PF, Gevaert Y, et al. Direct stimulation of cytokines (fL1 bêta, TNF-alpha, IL-6, IL-2, IFN-gamma and GM-CSF) in whole blood. I. Comparison with isolated PBMC stimulation. Cytokine. 1992;4:239-248.
45. Roubenoff R, Harris TB, Abad LW, Wilson PF, Dallai GE, Dinarello CA. Monocyte cytokine production in an elderly population: effect of age and inflammation. J Gerontol Med Sci. 1998;53A:M20-M26.
46. Gon Y, Hashimoto S, Hayashi S, Koura T, Matsumoto K, Hone T. Lower serum concentrations of cytokines in elderly patients with pneumonia and the impaired production of cytokines by peripheral blood monocytes in the elderly. Clin Exp Immunol. 1996; 106:120-126.
47. Born J, Umgenannt D, Dodt C, et al. Cytokine production and lymphocyte subpopulations in aged humans: an assessment during nocturnal sleep. Mech Ageing Dev. 1995;84:113-126.
48. Fagiolo U, Cossarizza A, Scala E, et al. Increased cytokine production in mononuclear cells of healthy elderly people. Eur J Immunol. 1993;23:2375-2378.
49. Belmin J, Bernard C, Corman B, Merval R, Esposito B, Tedgui A. Increased production of tumor necrosis factor and interleukin-6 by arterial wall of aged rats. Am J Physiol 1995;268:H2288-H2293
50. Vandenabeele P, Fiers W. Is amyloidogenesis during Alzheimer's disease due to an IL-l-/IL-6-mediated "acute phase response" in the brain? ImmunolToday. 1991;12:217-219.
51. Benveniste EN, Huneycutt BS, Shrikant P, Ballestas ME. Second messenger systems in the regulation of cytokines and adhesion molecules in the central nervous system. Brain Behav Immunol. 1995;9:304~314.
52. Carton MJ, Keir G, Lakshmi MV, Thompson EJ. Age-related changes in cerebrospinal fluid protein concentrations. J Neural Sci. 1991 ; 104:74-80.
53. Perlmutter LS, Chui HC. Microangiopathy, the vascular basement membrane and Alzheimer's disease: a review. Brain Res Bull. 1990;24:677-686.
54. Mattila KM, Pirttila T, Blennow K, Wallin A, Viitanen M, Frey H. Altered blood-brain-barrier function in Alzheimer's disease? Acta Neuml Scand. 1994;89:192-198.
55. Zhan SS, Veerhuis R, Kamphorst W, Eikelenboom P. Distribution of beta amyloid associated proteins in plaques in Alzheimer's disease and in the non-demented elderly. Neurodegeneration. 1995;4:291-297.
56. Kalaria RN, Golde TE, Cohen ML, Younkin SG. Serum amyloid P in Alzheimer's disease. Implications for dysfunction of the blood-brain barrier. AnnNYAcadSci. 1991;640:145-148.
57. Nybo M, Olsen H, Jeune B, Andersen-Ranberg K, Nielsen EH, Svehag SE. Increased plasma concentration of serum amyloid P component in centenarians with impaired cognitive performance. Dementia. 1998;9:126-129.
58. Benigni F, Faggioni R, Sironi M, et al. TNF receptor p55 plays a major role in centrally mediated increases of serum IL-6 and corticosterone after intracerebroventricular injection of TNF. J Immunol. 1996; 157:5563-5568.
59. Laman JD, de Smet BJGL, Schoneveld A, van Meurs M. CD40-CD40L interactions in atherosclerosis. Immunol Today. 1997;18:272-277.
60. Heinrich J, Schulte H, Schonfeld R, Kohler E, Assmann G. Association of variables of coagulation, fibrinolysis and acute-phase with atherosclerosis in coronary and peripheral arteries and those arteries supplying the brain. Thromb Haemost. 1995;73:374-379.
61. Ligthart GJ, Corberand JX, Geertzen HG, Meinders AE, Knook DL, Hijmans W. Necessity of the assessment of health status in human immunogerontological studies: evaluation of the SENIEUR protocol. Mech Ageing Dev. 1990;55:89-105.
62. Caymans R, Haverkorn MJ, Valkenburg HA, Goslings WR. A prospective study of urinary-tract infections in a Dutch general practice. Lancet. 1976;ii:674-677.
63. Abrutyn E, Mossey J, Levison M, Boscia J, Pitsakis P, Kaye D. Epidemiology of asymptomatic bacteriuria in elderly women. J Am Geriatr Soc. 1991;39:388-393.
64. Meurman JH, Pajukoski H, Snellman S, Zeiler S, Sulkava R. Oral infections in home-living elderly patients admitted to an acute geriatric ward. J DentRes. 1997;76:1271-1276.
65. Silas F, Forman D, Yarnell JW, et al. Helicobacter pylori infection rates in relation to age and social class in a population of Welsh men. Gut. 1991;32:25-28.
66. Megraud F, Brassens RM, Denis F, Belbouri A, Hoa DQ. Seroepidemiology of campylobacter pylori infection in various populations. J Clin Micmbiol. 1989;27:1870-1873.